Mitochondrial agents for bipolar disorder
Version 4 2024-06-18, 07:43
Version 3 2024-06-13, 16:02
Version 2 2024-06-04, 14:08
Version 1 2018-05-31, 19:22
journal contribution
posted on 2024-06-18, 07:43 authored by C Pereira, V Chavarria, J Vian, Melanie AshtonMelanie Ashton, Michael BerkMichael Berk, Wolf MarxWolf Marx, Olivia DeanOlivia DeanMitochondrial agents for bipolar disorder
History
Journal
International Journal of NeuropsychopharmacologyVolume
21Pagination
550-569Location
EnglandLink to full text
ISSN
1461-1457eISSN
1469-5111Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, The AuthorsIssue
6Publisher
OXFORD UNIV PRESSUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatryNeurosciences & Neurologyadjunctivebipolar disordercomplimentary therapiesmitochondriaALPHA-LIPOIC ACIDACETYL-L-CARNITINEPLACEBO-CONTROLLED TRIALMAGNETIC-RESONANCE-SPECTROSCOPYMAJOR DEPRESSIVE DISORDERRANDOMIZED-CLINICAL-TRIALVITAMIN-D-RECEPTORCOMPLEX-I DEFICIENCYOBESE ZUCKER RATSDOUBLE-BLIND110999 Neurosciences not elsewhere classified920410 Mental HealthFaculty of HealthSchool of MedicineInnovation in Mental and Physical Health and Clinical TreatmentInstitute for Innovation in Mental and Physical Health and Clinical Translation3209 Neurosciences3202 Clinical sciences3214 Pharmacology and pharmaceutical sciences420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC